Private equity firm LLR Partners announced the final closing of LLR Equity Partners VII, L.P. (LLR 7) at $2.45 billion. LLR 7’s capital includes participation by LLR’s Partners and employees. LLR’s prior fund, LLR 6, closed in October 2020 at $1.8 billion, including the General Partner’s commitment.
LLR 7 also continues the firm’s 25-year history of investing in and partnering with lower middle market growth companies. Like its predecessor funds, LLR 7 will focus on the technology and healthcare sectors. With over 100 professionals, a dedicated value creation team, and a group of experienced executives engaged as Senior Operating Advisors, LLR 7 will invest in majority and minority equity positions, with capital for growth, recapitalizations, and buyouts.
Some of LLR 7’s capital commitments came from a global group of legacy and new investors. LLR 7 started investing in 2024 and has completed investments in five companies: KEEPS, Nonstop Health, Soltis Investment Advisors, Suvoda, and TurboTenant.
LLR was founded in 1999 and has raised more than $7 billion across seven funds.
Placement agent/counsel: Asante Capital Group acted as placement agent and Latham & Watkins provided legal counsel for LLR 7.
KEY QUOTES:
“We thank our investors for their partnership and confidence in LLR’s investment strategy. We greatly value our Limited Partners, with the entire LLR team striving every day to deliver for them.”
Partner Mitchell Hollin
“Our thesis-driven investment approach, tech-enabled origination and extensive value creation resources put LLR in prime position to help our companies accelerate growth and become market leaders. Our shared objective continues: together, we grow companies every day.”
Managing Director, Investor Relations Jason Jerista
